av/protalix-biotherapeutics--big.svg

COM:PROTALIX

Protalix Biotherapeutics

  • Stock

USD

Last Close

1.66

22/11 21:00

Market Cap

82.11M

Beta: -

Volume Today

545.62K

Avg: -

  • name

    Protalix BioTherapeutics, Inc.
  • homepage url

    www.protalix.com
  • country

    USUnited States
  • employee count

    208
  • sector

    Healthcare
  • industry

    Biotechnology
  • revenue

    65.49M

Description

Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso for the treatment of Gaucher diseas...Show More

peer of

competitor of